Price $7.80 |
Market Cap
62.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
26.9
|
P/B
-
|
P/S
1.92
|
Dividend %
-
|
|
P/CF
311.6
|
P/FCF
12.3
|
Op. Cash Flow
6K
|
FCF
0.6
|
|
Op. Margin
16.80%
|
Net Margin
7.20%
|
ROE
-29.00%
|
ROI
94.90%
|
|
ROA
5.50%
|
EPS Growth
294.30%
|
Current Ratio
1.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH) | $142.57 | - | 0.70% | 28.38B | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLNF) | $0.70 | - | - | 13.1M | Strong Buy |
| Novan Inc (NOVN) | $1.98 | - | - | 57.4M | Strong Buy |
| Natus Medical Inc (NTUS) | $31.69 | - | - | 1.15B | Strong Buy |
| MTBC Inc (MTBC) | $3.94 | - | - | 43.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
